Ameritas Investment Partners’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Ameritas Investment Partners’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-122	Closed	-$4.42K	–	3248
2023 Q1	$4.42K	Hold	122	–	–	﹤0.01%	2878
2022 Q4	$9.79K	Hold	122	–	–	﹤0.01%	2810
2022 Q3	$9K	Hold	122	–	–	﹤0.01%	2840
2022 Q2	$13K	Hold	122	–	–	﹤0.01%	2767
2022 Q1	$23K	Buy	122 +92	+307%	+$21.3K	﹤0.01%	2507
2021 Q4	$10K	Hold	30	–	–	﹤0.01%	2913
2021 Q3	$10K	Buy	+30	New	+$15.4K	﹤0.01%	2948

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameritas Investment Partners's OMIC Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 122 shares — an estimated $4.42K sold.

Ameritas Investment Partners first reported a position in OMIC in Q3 2021 and held it in 7 quarters. The position peaked at $23K in Q1 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

Ameritas Investment Partners reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ameritas Investment Partners sold 122 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $4.42K.
Ameritas Investment Partners first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Ameritas Investment Partners's Singular Genomics Systems, Inc. Common Stock position peaked at $23K in Q1 2022.
62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.